Bhubaneswar: A day after the Drugs Controller General of India (DCGI) formally approved the emergency use of two vaccines in the country, the Odisha government on Monday said that it ...
New Delhi: Congress leaders Shashi Tharoor and Jairam Ramesh, along with Akhilesh Yadav of Samajwadi Party, have raised objections to coronavirus vaccine Covaxin being approved without efficacy data. "Covaxin has ...
New Delhi: Lauding the final approval of the Drugs Controller General of India (DCGI) on Sunday to two COVID-19 vaccines, All India Institute Of Medical Science (AIIMS) Director Randeep Guleria ...
New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from the Drugs Controller ...
New Delhi: The All India Drug Action Network (AIDAN) has asked the Drugs Controller General of India (DCGI) to reconsider SEC recommendation in granting REU approval to Bharat Biotech-developed COVAXIN. ...
New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, ...
Hyderabad: COVID-19 vaccine, Covaxin will be effective in treating the new strain that has created a panic worldwide, Bharat Biotech said on Tuesday. According to Bharat Biotech Chairman and Managing ...
New Delhi: Home-grown COVID-19 vaccine Covaxin has shown to develop long-term antibody and T-cell memory responses 3 months after the shot in Phase-1 trials. Bharat Biotech said the safety outcome ...
New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with ...
New Delhi: Serum Institute of India (SII) and Bharat Biotech have not been granted emergency use authorisation of their coronavirus vaccine because of inadequate safety and efficacy data. According to ...